UMIN ID: C000000067
Registered date:18/08/2005
Randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer (JCOG9206-2)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | gastric neoplasm |
| Date of first enrollment | 1993/01/01 |
| Target sample size | 280 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Surgery (Gastrectomy with D2 or greater lymph node dissection) Surgery + chemotherapy |
Outcome(s)
| Primary Outcome | Overall survival |
|---|---|
| Secondary Outcome | Relapse-free survival, the site of recurrence |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1) Prior chemotherapy or radiotherapy (2) Synchronous or metachronous malignancy in other organs |
Related Information
| Primary Sponsor | Japan Clinical Oncology Group(JCOG) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
| Secondary ID(s) | NCT00147147 |
Contact
| public contact | |
| Name | Mitsuru Sasako, MD, PhD |
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 JAPAN Japan |
| Telephone | |
| JCOG_sir@ml.jcog.jp | |
| Affiliation | JCOG9206-2 Coordinating Office Gastric Surgery Division, National Cancer Center Hospital |
| scientific contact | |
| Name | Hiroshi Furukawa, MD, PhD |
| Address | 1-1-1 Minamiyasui-cho, Sakai, Osaka 590-0064, JAPAN Japan |
| Telephone | |
| Affiliation | Sakai Municipal Hospital Surgery |